Cargando…
5-Amino-1-β-D-Ribofuranosyl-Imidazole-4-Carboxamide (AICAR) Reduces Peripheral Inflammation by Macrophage Phenotype Shift
The stimulation of the AMP-activated kinase (AMPK) by 5-amino-1-β-D-ribofuranosyl-imidazole-4-carboxamide (AICAR) has been associated with antihyperalgesia and the inhibition of nociceptive signaling in the spinal cord in models of paw inflammation. The attenuated nociception comes along with a stro...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651813/ https://www.ncbi.nlm.nih.gov/pubmed/31269729 http://dx.doi.org/10.3390/ijms20133255 |
_version_ | 1783438431439814656 |
---|---|
author | Martin, Lisa Maria Möller, Moritz Weiss, Ulrike Russe, Otto Quintus Scholich, Klaus Pierre, Sandra Geisslinger, Gerd Niederberger, Ellen |
author_facet | Martin, Lisa Maria Möller, Moritz Weiss, Ulrike Russe, Otto Quintus Scholich, Klaus Pierre, Sandra Geisslinger, Gerd Niederberger, Ellen |
author_sort | Martin, Lisa Maria |
collection | PubMed |
description | The stimulation of the AMP-activated kinase (AMPK) by 5-amino-1-β-D-ribofuranosyl-imidazole-4-carboxamide (AICAR) has been associated with antihyperalgesia and the inhibition of nociceptive signaling in the spinal cord in models of paw inflammation. The attenuated nociception comes along with a strongly reduced paw edema, indicating that peripheral antiinflammatory mechanisms contribute to antinociception. In this study, we investigated the impact of AICAR on the immune cell composition in inflamed paws, as well as the regulation of inflammatory and resolving markers in macrophages. By using fluorescence-activated cell sorting (FACS) analysis and immunofluorescence, we found a significantly increased fraction of proresolving M2 macrophages and anti-inflammatory interleukin (IL)-10 in inflamed tissue, while M1 macrophages and proinflammatory cytokines such as IL-1 were decreased by AICAR in wild type mice. In AMPKα2 knock-out mice, the M2 polarization of macrophages in the paw was missing. The results were supported by experiments in primary macrophage cultures which also showed a shift to a proresolving phenotype with decreased levels of proinflammatory mediators and increased levels of antiinflammatory mediators. However, in the cell cultures, we did not observe differences between the AMPKα2+/+ and −/− cells, thus indicating that the AICAR-induced effects are at least partially AMPK-independent. In summary, our results indicate that AICAR has potent antiinflammatory and proresolving properties in inflammation which are contributing to a reduction of inflammatory edema and antinociception. |
format | Online Article Text |
id | pubmed-6651813 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-66518132019-08-08 5-Amino-1-β-D-Ribofuranosyl-Imidazole-4-Carboxamide (AICAR) Reduces Peripheral Inflammation by Macrophage Phenotype Shift Martin, Lisa Maria Möller, Moritz Weiss, Ulrike Russe, Otto Quintus Scholich, Klaus Pierre, Sandra Geisslinger, Gerd Niederberger, Ellen Int J Mol Sci Article The stimulation of the AMP-activated kinase (AMPK) by 5-amino-1-β-D-ribofuranosyl-imidazole-4-carboxamide (AICAR) has been associated with antihyperalgesia and the inhibition of nociceptive signaling in the spinal cord in models of paw inflammation. The attenuated nociception comes along with a strongly reduced paw edema, indicating that peripheral antiinflammatory mechanisms contribute to antinociception. In this study, we investigated the impact of AICAR on the immune cell composition in inflamed paws, as well as the regulation of inflammatory and resolving markers in macrophages. By using fluorescence-activated cell sorting (FACS) analysis and immunofluorescence, we found a significantly increased fraction of proresolving M2 macrophages and anti-inflammatory interleukin (IL)-10 in inflamed tissue, while M1 macrophages and proinflammatory cytokines such as IL-1 were decreased by AICAR in wild type mice. In AMPKα2 knock-out mice, the M2 polarization of macrophages in the paw was missing. The results were supported by experiments in primary macrophage cultures which also showed a shift to a proresolving phenotype with decreased levels of proinflammatory mediators and increased levels of antiinflammatory mediators. However, in the cell cultures, we did not observe differences between the AMPKα2+/+ and −/− cells, thus indicating that the AICAR-induced effects are at least partially AMPK-independent. In summary, our results indicate that AICAR has potent antiinflammatory and proresolving properties in inflammation which are contributing to a reduction of inflammatory edema and antinociception. MDPI 2019-07-02 /pmc/articles/PMC6651813/ /pubmed/31269729 http://dx.doi.org/10.3390/ijms20133255 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Martin, Lisa Maria Möller, Moritz Weiss, Ulrike Russe, Otto Quintus Scholich, Klaus Pierre, Sandra Geisslinger, Gerd Niederberger, Ellen 5-Amino-1-β-D-Ribofuranosyl-Imidazole-4-Carboxamide (AICAR) Reduces Peripheral Inflammation by Macrophage Phenotype Shift |
title | 5-Amino-1-β-D-Ribofuranosyl-Imidazole-4-Carboxamide (AICAR) Reduces Peripheral Inflammation by Macrophage Phenotype Shift |
title_full | 5-Amino-1-β-D-Ribofuranosyl-Imidazole-4-Carboxamide (AICAR) Reduces Peripheral Inflammation by Macrophage Phenotype Shift |
title_fullStr | 5-Amino-1-β-D-Ribofuranosyl-Imidazole-4-Carboxamide (AICAR) Reduces Peripheral Inflammation by Macrophage Phenotype Shift |
title_full_unstemmed | 5-Amino-1-β-D-Ribofuranosyl-Imidazole-4-Carboxamide (AICAR) Reduces Peripheral Inflammation by Macrophage Phenotype Shift |
title_short | 5-Amino-1-β-D-Ribofuranosyl-Imidazole-4-Carboxamide (AICAR) Reduces Peripheral Inflammation by Macrophage Phenotype Shift |
title_sort | 5-amino-1-β-d-ribofuranosyl-imidazole-4-carboxamide (aicar) reduces peripheral inflammation by macrophage phenotype shift |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651813/ https://www.ncbi.nlm.nih.gov/pubmed/31269729 http://dx.doi.org/10.3390/ijms20133255 |
work_keys_str_mv | AT martinlisamaria 5amino1bdribofuranosylimidazole4carboxamideaicarreducesperipheralinflammationbymacrophagephenotypeshift AT mollermoritz 5amino1bdribofuranosylimidazole4carboxamideaicarreducesperipheralinflammationbymacrophagephenotypeshift AT weissulrike 5amino1bdribofuranosylimidazole4carboxamideaicarreducesperipheralinflammationbymacrophagephenotypeshift AT russeottoquintus 5amino1bdribofuranosylimidazole4carboxamideaicarreducesperipheralinflammationbymacrophagephenotypeshift AT scholichklaus 5amino1bdribofuranosylimidazole4carboxamideaicarreducesperipheralinflammationbymacrophagephenotypeshift AT pierresandra 5amino1bdribofuranosylimidazole4carboxamideaicarreducesperipheralinflammationbymacrophagephenotypeshift AT geisslingergerd 5amino1bdribofuranosylimidazole4carboxamideaicarreducesperipheralinflammationbymacrophagephenotypeshift AT niederbergerellen 5amino1bdribofuranosylimidazole4carboxamideaicarreducesperipheralinflammationbymacrophagephenotypeshift |